Results 311 to 320 of about 193,013 (355)
Some of the next articles are maybe not open access.
Archives of Family Medicine, 1996
Diabetic nephropathy is an important microvascular complication of both insulin-dependent and non-insulin-dependent diabetes mellitus. It is the leading cause of end-stage renal disease. The natural course, pathogenesis, clinical evaluation, and treatment of diabetic nephropathy were reviewed, with special emphasis on recent important studies of ...
openaire +2 more sources
Diabetic nephropathy is an important microvascular complication of both insulin-dependent and non-insulin-dependent diabetes mellitus. It is the leading cause of end-stage renal disease. The natural course, pathogenesis, clinical evaluation, and treatment of diabetic nephropathy were reviewed, with special emphasis on recent important studies of ...
openaire +2 more sources
Irish Journal of Medical Science, 1979
Since the original recognition by Kimmelstiel and Wilson in 1936 of a characteristic nodular lesion in diabetic renal glomeruli, no simple relationship has been demonstrated between the structural and functional defects now known to exist in diabetic renal disease.
openaire +2 more sources
Since the original recognition by Kimmelstiel and Wilson in 1936 of a characteristic nodular lesion in diabetic renal glomeruli, no simple relationship has been demonstrated between the structural and functional defects now known to exist in diabetic renal disease.
openaire +2 more sources
Current Opinion in Internal Medicine, 2003
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire +2 more sources
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire +2 more sources
Proteomics and Diabetic Nephropathy
Seminars in Nephrology, 2005Diabetes mellitus is acknowledged to be a group of metabolic diseases and heterogeneous in natural history, pathogenesis, response to treatment, and disease progression and remission. Diabetic nephropathy (DN) accounts for approximately 40% of all newly diagnosed cases of end-stage renal disease.
Michael L, Merchant, Jon B, Klein
openaire +3 more sources
Diabetic Nephropathy and Pregnancy
Clinical Obstetrics and Gynecology, 1991Knowledge of the pathogenic mechanisms of diabetic nephropathy (by which hyperglycemia, hyperfiltration, and hypertension cause the gradual development of microproteinuria, mesangial expansion, and eventual glomerular closure) provides the basis for effective treatment.
C A, Combs, J L, Kitzmiller
openaire +3 more sources
2012
The most common cause of end stage renal disease (ESRD) requiring dialysis is diabetes. Both environmental and genetic factors have been postulated as the risk factors of Diabetic Nephropathy (DN). Hyperglycemia-induced metabolic and hemodynamic pathways are recognized to be mediators of kidney injury. Multiple biochemical pathways have been postulated
openaire +2 more sources
The most common cause of end stage renal disease (ESRD) requiring dialysis is diabetes. Both environmental and genetic factors have been postulated as the risk factors of Diabetic Nephropathy (DN). Hyperglycemia-induced metabolic and hemodynamic pathways are recognized to be mediators of kidney injury. Multiple biochemical pathways have been postulated
openaire +2 more sources
Archives of Internal Medicine, 1990
The discovery and isolation of insulin earlier in this century proved a life-saving advance for many diabetics. But with this treatment new challenges emerged—the progressive systemic microvascular and macrovascular injuries that limit both the quality and duration of life of these patients.
openaire +2 more sources
The discovery and isolation of insulin earlier in this century proved a life-saving advance for many diabetics. But with this treatment new challenges emerged—the progressive systemic microvascular and macrovascular injuries that limit both the quality and duration of life of these patients.
openaire +2 more sources
Experimental and Clinical Endocrinology & Diabetes, 2023
Ludwig, Merker +3 more
openaire +2 more sources
Ludwig, Merker +3 more
openaire +2 more sources